RadNet (RDNT) vs. Its Competitors Critical Analysis

RadNet (NASDAQ:RDNT) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its peers? We will compare RadNet to related companies based on the strength of its risk, institutional ownership, analyst recommendations, dividends, earnings, profitability and valuation.

Valuation & Earnings

This table compares RadNet and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
RadNet	$2.04 billion	-$18.65 million	-288.67
RadNet Competitors	$21.22 billion	$301.67 million	7.15

RadNet’s peers have higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for RadNet and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1	0	6	2	3.00
RadNet Competitors	1863	7734	13360	822	2.55

RadNet presently has a consensus target price of $90.43, suggesting a potential upside of 16.02%. As a group, “Healthcare Providers & Services” companies have a potential upside of 12.99%. Given RadNet’s stronger consensus rating and higher probable upside, research analysts clearly believe RadNet is more favorable than its peers.

Volatility and Risk

RadNet has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Comparatively, RadNet’s peers have a beta of 0.98, suggesting that their average share price is 2% less volatile than the S&P 500.

Profitability

This table compares RadNet and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
RadNet	-0.94%	3.14%	1.08%
RadNet Competitors	-8.06%	-138.13%	-1.54%

Insider & Institutional Ownership

77.9% of RadNet shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 5.1% of RadNet shares are held by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

RadNet beats its peers on 10 of the 13 factors compared.

About RadNet

RadNet, Inc. operates outpatient diagnostic imaging centers in the United States. Its centers provide services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, ultrasound, X-ray and nuclear medicine imaging. The company serves patients, physicians and healthcare organizations, with operations across several states, including California, Delaware, Florida, Maryland, New Jersey and New York. Its imaging centers offer diagnostic services for a range of medical needs, from routine screening to specialized examinations.